Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Howard C. Margolese |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder / Howard C. Margolese en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 4 (Agosto)
[artículo]
Título : Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder Tipo de documento: texto impreso Autores: Howard C. Margolese, Autor ; Guy Chouinard, Autor ; Linda Beauclair, Autor Fecha de publicación: 2023 Artículo en la página: pp. 347-352 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Tolerancia al medicamento, Psicosis inducidas por sustancias, Trastornos psicóticos, Esquizofrenia. Resumen: A 3-year open-label study was conducted to determine the long-term safety and efficacy of quetiapine monotherapy in schizophrenia and schizoaffective disorder. Twenty-three male outpatients previously stable but with inter-episode residual symptoms on classical antipsychotics and/or risperidone and who had complained of side effects were selected.
Link: ./index.php?lvl=notice_display&id=31049
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 347-352[artículo] Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder [texto impreso] / Howard C. Margolese, Autor ; Guy Chouinard, Autor ; Linda Beauclair, Autor . - 2023 . - pp. 347-352.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 347-352
Palabras clave: Antipsicóticos, Tolerancia al medicamento, Psicosis inducidas por sustancias, Trastornos psicóticos, Esquizofrenia. Resumen: A 3-year open-label study was conducted to determine the long-term safety and efficacy of quetiapine monotherapy in schizophrenia and schizoaffective disorder. Twenty-three male outpatients previously stable but with inter-episode residual symptoms on classical antipsychotics and/or risperidone and who had complained of side effects were selected.
Link: ./index.php?lvl=notice_display&id=31049